Search results
Results From The WOW.Com Content Network
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) is a questionnaire that can be filled out by a relative or other supporter of an older person to determine whether that person has declined in cognitive functioning. The IQCODE is used as a screening test for dementia. If the person is found to have significant cognitive ...
Radiation-induced cognitive decline describes the possible correlation between radiation therapy and cognitive impairment. Radiation therapy is used mainly in the treatment of cancer. Radiation therapy can be used to cure, care or shrink tumors that are interfering with quality of life. Sometimes radiation therapy is used alone; other times it ...
Scientists announced in December the successful creation of the Brain Care Score, a tool for assessing dementia or stroke risk without medical procedures. That score, which also helps patients and ...
An estimated 5.8 million people in the U.S. have Alzheimer’s disease and related dementias, but the condition can be tricky to diagnose.Patients usually are put through a series of tests, and it ...
ADAS-Cog. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1] and is considered to be the “gold standard” for assessing antidementia treatments.
DR. NOOR SHAIK. Deaths from dementia have tripled in just 21 years, according to a new study published in The Primary Care Companion for CNS Disorders. In 1999, about 150,000 Americans died from ...
Purpose. test cognitive impairment. The Addenbrooke's Cognitive Examination (ACE) and its subsequent versions (Addenbrooke's Cognitive Examination-Revised, ACE-R [ 1] and Addenbrooke's Cognitive Examination III, ACE-III) are neuropsychological tests used to identify cognitive impairment in conditions such as dementia .
Medication Appropriateness Tool for Comorbid Health conditions during Dementia. The Medication Appropriateness Tool for Comorbid Health conditions during Dementia ( MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself. [1] [2]